提高帕金森病患者责任感的职业:国际德尔菲研究
Mahsa Meimandi1, Ghorban Taghizadeh2, Philip von Rosen3
1Mahsa Meimandi, MSc, is PhD Candidate, Rehabilitation Research Center, Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
概括
专家们确定了61个职业,这些职业可以提高帕金森病患者的责任感. 这项研究有助于制定有效的,专注于职业的康复策略,以改善日常生活和结果.
科学领域:
- 神经科学与康复治疗
- 职业疗法 职业疗法 职业疗法
- 代理机构的心理学
背景情况:
- 在帕金森病 (PD) 中,自愿行动受损,影响了代理和责任感.
- 缺乏关于PD康复责任的研究限制了基于证据的职业治疗.
- 了解和培养责任感对于患者的参与和结果至关重要.
研究的目的:
- 建立基于共识的职业列表,以增强患有PD的个体内在的责任感.
- 确定与患者相关的关键信息,这些信息对于提供有效,以职业为中心的干预至关重要.
主要方法:
- 一个匿名的,代的两轮德尔菲研究,利用电子调查.
- 第1轮有116名专家参加,第2轮有95名专家参加.
- 关于职业和信息的重要性的共识是使用5分利克特比例和四分位数范围>1.1的四分位数范围来确定的.
主要成果:
- 在61个职业上达成共识,这些职业可以提高PD患者中等到非常高的责任感.
- 达成一致意见是,许多与患者相关的信息类型对于干预交付的重要性.
- 第二轮提交的所有项目都达成了共识,验证了专家小组的投入.
结论:
- 可以利用大量的职业来增强PD患者的责任感.
- 具体的患者信息对于优化以职业为中心的干预至关重要.
- 将主观代理及其后果的理解融入康复中,可以提高患者的福祉和功能结果.
相关概念视频
01:24Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
01:15Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598